They found that immunotarget anti- PD-L1 antibody and NTP-conjugated gold NPs could specifically bind to SCC-25 cells and induced an increase in the selective uptake of anti-PD-L1 antibody + GNP on SCC-25 cells, but significantly reduced tumor cell viability. This evidence concerns the gene CD274 and neoplasm.